Anti-Diabetic Drug, The Largest-Selling Medicine In India
BANGALORE: By adopting the latest lifestyles many of the people have become prey to several diseases like diabetes. But now people can protect themselves from these diseases by using the latest anti-diabetic drug and it seems that this drug sale is flourishing. This anti-diabetic molecule has for the first time become the largest-selling formulation in the domestic pharma retail market. This latest anti-diabetic drug is also one of the most prescribed too, and it is a combination of glimepiride and metformin and it has dethroned the popular class of anti-infective medicines, led by widely-used medicine brands like GSK's Augmentin (a combination of amoxycillin and clavulanic acid) in May reports TNN.
The therapy, which generated revenue of 103 crore in May, is the first diabetes treatment to become the top-selling medication in the country. Even the analysts tracking the market said the anti-infective therapy had always been ranked on top. The primary reason behind the flourishing sales for the anti-diabetic molecule is its faster growth, as well as the anti-infective molecule coming under price control. Sales of Gluconorm, which consists of the combination of metformin and glimepiride, grew by 34.4 percent last month, versus about 4 percent for Augmentin.
Lauren from www.doctor-4-u.co.uk said: 'Weight loss drugs are ever increasing in demand as they become a more popular method of losing weight. The use of oral medication is after all a lot easier then engaging in regular fitness and maintaining a healthy diet.'